Expand HCWB Menu
HCWB MENU

HCWB Latest Press Releases

-- March 31, 2026 --

HCW Biologics Reports Fourth Quarter 2025 and Fiscal Year 2025 Business Highlights and Financial Results Globe Newswire 5:05 PM

-- March 17, 2026 --

HCW Biologics Closes Exclusive Worldwide License for HCW11-006 - A High Potential Fusion Immunotherapeutic Globe Newswire 7:50 AM

-- March 16, 2026 --

HCW Biologics Announces Positive Research Results for CAR-T Cell Therapy Manufactured Utilizing Its Commercial-Ready Proprietary Compound, HCW9206, Published in Science Advances Globe Newswire 8:00 AM

-- March 2, 2026 --

HCW Biologics Regains Compliance with All Continued Listing Rules for Nasdaq Per Nasdaq Determination Letter Globe Newswire 8:00 AM

-- February 19, 2026 --

Alopecia Areata Market Set to Expand by 2036, Due to the Emergence of Novel Drug Classes Such as OX40L Inhibitors, IL-2 Inhibitors, IL-7Ra, and Others | DelveInsight PRNewswire 5:31 PM

-- February 17, 2026 --

HCW Biologics Announces Pricing of $1.5 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules Globe Newswire 9:50 PM

-- February 13, 2026 --

HCW Biologics and WY Biotech Announce Closing of First Round of Financing For Newly Formed Joint Venture Trimmune Globe Newswire 8:30 AM

-- November 19, 2025 --

HCW Biologics Enters into $4.0 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules Globe Newswire 8:30 AM

-- November 18, 2025 --

HCW Biologics Announces Initiation of First-In-Human Clinical Trial to Evaluate HCW9302 in an Autoimmune Disease Globe Newswire 7:25 AM

-- November 14, 2025 --

HCW Biologics Reports Third Quarter 2025 Business Highlights and Financial Results Globe Newswire 4:44 PM
Market Data Delayed 15 Minutes